Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept

Monitoring measurable residual disease (MRD) is crucial to assess treatment response in Multiple Myeloma (MM). Detection of MRD in peripheral blood (PB) by exploring Extracellular Vesicles (EVs), and their cargo, would allow frequent and minimally invasive monitoring of MM. This work aims to detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergantim, Rui, Peixoto da Silva, Sara, Polónia, Bárbara, Barbosa, Mélanie A. G., Albergaria, André, Lima, Jorge, Caires, Hugo R., Guimarães, José E., Vasconcelos, M. Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690807/
https://www.ncbi.nlm.nih.gov/pubmed/36430163
http://dx.doi.org/10.3390/ijms232213686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690807/
https://www.ncbi.nlm.nih.gov/pubmed/36430163
http://dx.doi.org/10.3390/ijms232213686

Ejemplares similares